Perspective Therapeutics, Inc. SEC filings

Filings

1. 8-KPerspective Therapeutics, Inc.CATXOct 8

   Perspective Therapeutics gains FDA Fast Track for PSV359

   • FDA granted Fast Track Designation for PSV359 on 2026-10-08.
   • PSV359 targets FAP-positive solitary fibrous tumors.
   • Fast Track may allow for expedited review and potential accelerated approval.
2. 8-KPerspective Therapeutics, Inc.CATXOct 1

   Current report

3. SCHEDULE 13D/APerspective Therapeutics, Inc.CATXSep 23

   Ownership stake disclosure by Lantheus Holdings, Inc. (amended)

   Lantheus Holdings, Inc., filed by

4. 8-KPerspective Therapeutics, Inc.CATXSep 14

   Current report

5. 8-KPerspective Therapeutics, Inc.CATXSep 8

   Current report

6. 4Perspective Therapeutics, Inc.CATXSep 8

   Lantheus Holdings, Inc., insider filing for CATX

   Lantheus Holdings, Inc., reporting · Lantheus Alpha Therapy, LLC, reporting

7. 4Perspective Therapeutics, Inc.CATXSep 4

   2 insider filings

   Lantheus Holdings, Inc., insider filing for CATX

   Show all 2

   • 4Insider filing for CATXSep 4
   • 4Insider filing for CATXSep 4

   Lantheus Holdings, Inc., reporting · Lantheus Alpha Therapy, LLC, reporting

8. SCHEDULE 13D/APerspective Therapeutics, Inc.CATXSep 4

   Ownership stake disclosure by Lantheus Holdings, Inc. (amended)

   Lantheus Holdings, Inc., filed by

9. 4Perspective Therapeutics, Inc.CATXSep 3

   Lantheus Holdings, Inc., insider filing for CATX

   Lantheus Holdings, Inc., reporting

10. 4Perspective Therapeutics, Inc.CATXSep 2

    Lantheus Holdings, Inc., insider filing for CATX

    Lantheus Holdings, Inc., reporting

11. SCHEDULE 13G/APerspective Therapeutics, Inc.CATXAug 13

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC (amended)

    MILLENNIUM MANAGEMENT LLC, filed by

12. 10-QPerspective Therapeutics, Inc.CATXAug 10

    Quarterly report

13. 8-KPerspective Therapeutics, Inc.CATXAug 10

    Current report

14. SCHEDULE 13GPerspective Therapeutics, Inc.CATXAug 7

    Ownership stake disclosure by STATE STREET CORP

    STATE STREET CORP, filed by

15. 8-KPerspective Therapeutics, Inc.CATXAug 3

    Current report

16. SCHEDULE 13GPerspective Therapeutics, Inc.CATXJul 29

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

17. SCHEDULE 13GPerspective Therapeutics, Inc.CATXJul 20

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

18. 8-KPerspective Therapeutics, Inc.CATXJul 1

    Current report

19. SCHEDULE 13GPerspective Therapeutics, Inc.CATXJun 30

    Ownership stake disclosure by MILLENNIUM MANAGEMENT LLC

    MILLENNIUM MANAGEMENT LLC, filed by

20. 8-KPerspective Therapeutics, Inc.CATXJun 1

    Current report

21. 8-KPerspective Therapeutics, Inc.CATXMay 27

    Current report

22. SCHEDULE 13G/APerspective Therapeutics, Inc.CATXMay 12

    Ownership stake disclosure by Stanley Morgan (amended)

    Stanley Morgan, filed by

23. 10-QPerspective Therapeutics, Inc.CATXMay 11

    Quarterly report

24. 8-KPerspective Therapeutics, Inc.CATXMay 11

    Current report

25. 8-KPerspective Therapeutics, Inc.CATXMay 4

    Current report

26. SCHEDULE 13G/APerspective Therapeutics, Inc.CATXApr 27

    Ownership stake disclosure by BlackRock, Inc. (amended)

    BlackRock, Inc., filed by

27. 8-KPerspective Therapeutics, Inc.CATXApr 20

    Current report

28. DEFA14APerspective Therapeutics, Inc.CATXApr 16

    Additional proxy materials

29. DEF 14APerspective Therapeutics, Inc.CATXApr 16

    Proxy statement

30. 8-KPerspective Therapeutics, Inc.CATXApr 1

    Current report

31. 10-KPerspective Therapeutics, Inc.CATXMar 16

    Annual report

32. 8-KPerspective Therapeutics, Inc.CATXMar 16

    Current report

33. SCHEDULE 13GPerspective Therapeutics, Inc.CATXMar 10

    Ownership stake disclosure by Avidity Partners Management LP

    Avidity Partners Management LP, filed by

34. 4Perspective Therapeutics, Inc.CATXMar 4

    8 insider filings

    Maria E Martinez, insider filing for CATX

    Show all 8

    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4
    • 4Insider filing for CATXMar 4

    Maria E Martinez, reporting

35. SCHEDULE 13GPerspective Therapeutics, Inc.CATXFeb 12

    Ownership stake disclosure by Stanley Morgan

    Stanley Morgan, filed by

36. SCHEDULE 13GPerspective Therapeutics, Inc.CATXFeb 9

    Ownership stake disclosure by Commodore Capital LP

    Commodore Capital LP, filed by

37. SCHEDULE 13GPerspective Therapeutics, Inc.CATXFeb 6

    Ownership stake disclosure by TCG Crossover GP II, LLC

    TCG Crossover GP II, LLC, filed by

38. SCHEDULE 13GPerspective Therapeutics, Inc.CATXFeb 5

    Ownership stake disclosure by Qatar Investment Authority

    Qatar Investment Authority, filed by

39. 8-KPerspective Therapeutics, Inc.CATXFeb 3

    Current report

40. FWPPerspective Therapeutics, Inc.CATXFeb 2

    Securities offering

41. 8-KPerspective Therapeutics, Inc.CATXFeb 2

    Current report

42. 8-KPerspective Therapeutics, Inc.CATXJan 14

    Current report

Older filings on EDGAR